aod9604 fda approval status AOD-9604 failed its trials and got dismissed as ineffective. the actual story is more specific — and more instructive. 🧩 the compound is a fragment of human growth hormone, isolated from Syringe:29G Lipolytic Fragment 5-Amino-1MQ Dosage & Protocol

aod9604 fda approval status AOD-9604 failed its trials and got dismissed as ineffective. the actual story is more specific — and more instructive. 🧩 the compound is a fragment of human growth hormone, isolated from Syringe:29G Lipolytic Fragment 5-Amino-1MQ Dosage & Protocol

5-Amino-1MQ Dosage & Protocol — Recomp, NAD+ & Stacks | Biomogging | Biomogging

Selectivity matters: SAM is used by dozens of methyltransferases, and a non-selective SAM-depleting agent would interfere broadly with methylation biology

Lipolytic Fragment

Syringe:29G

These statements have not been evaluated as treatment, cure, or prevention claims